Megasys Biotek Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 7.00 Cr
as on 04-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 04-12-2024
- Satisfied Charges ₹ 7.80 Cr
as on 04-12-2024
- Revenue -18.84%
(FY 2021)
- Profit -37.20%
(FY 2021)
- Ebitda -25.76%
(FY 2021)
- Net Worth 19.46%
(FY 2021)
- Total Assets -29.19%
(FY 2021)
About Megasys Biotek
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹7.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Kannampalam, Padmadas Panjajanyam, Thomsan George, and Two other members serve as directors at the Company.
- CIN/LLPIN
U52311KL2005PTC017869
- Company No.
017869
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2005
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Megasys Biotek Private Limited offer?
Megasys Biotek Private Limited offers a wide range of products and services, including Common Disease Medicines, Eye Drops.
Who are the key members and board of directors at Megasys Biotek?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Kannampalam  | Managing Director | 03-Nov-2016 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomsan George | Director | 03-Nov-2016 | Current |
| Padmadas Panjajanyam | Director | 31-May-2017 | Current |
| Sharatkumar Kumarakurup | Director | 31-May-2017 | Current |
| Narayan Biji | Director | 31-May-2017 | Current |
Financial Performance of Megasys Biotek.
Megasys Biotek Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 18.84% decrease. The company also saw a substantial fall in profitability, with a 37.2% decrease in profit. The company's net worth Soared by an impressive increase of 19.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Megasys Biotek?
In 2021, Megasys Biotek had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akesiss Pharma Private LimitedActive 16 years 1 monthAshok Kannampalam, Padmadas Panjajanyam and 3 more are mutual person
Akesiss Healthcare LlpActive 5 years 5 monthsAshok Kannampalam, Padmadas Panjajanyam and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2016 | ₹2.00 Cr | Open |
Others Creation Date: 30 Dec 2016 | ₹7.00 M | Satisfied |
Others Creation Date: 30 Dec 2016 | ₹2.60 Cr | Satisfied |
How Many Employees Work at Megasys Biotek?
Megasys Biotek has a workforce of 85 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Megasys Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megasys Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
